Albert David Limited (ALBERTDAVD.NS)
INR 791.6
(2.14%)
INR 791.6
(2.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 754.2 Million INR | 108.49% |
| 2022 | 361.74 Million INR | 2.6% |
| 2021 | 352.58 Million INR | 59.23% |
| 2020 | 221.43 Million INR | 15.52% |
| 2019 | 191.68 Million INR | -28.05% |
| 2018 | 266.39 Million INR | 170.71% |
| 2017 | 98.4 Million INR | -18.23% |
| 2016 | 120.35 Million INR | -74.92% |
| 2015 | 479.95 Million INR | 250.33% |
| 2014 | 137 Million INR | 8.96% |
| 2013 | 125.73 Million INR | 46.91% |
| 2012 | 85.58 Million INR | 12.2% |
| 2011 | 76.28 Million INR | -29.66% |
| 2010 | 108.45 Million INR | 5.57% |
| 2009 | 102.74 Million INR | 36.51% |
| 2008 | 75.26 Million INR | 2.54% |
| 2007 | 73.39 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 188.44 Million INR | 45.94% |
| 2023 Q3 | 187.17 Million INR | -7.79% |
| 2023 Q4 | 129.12 Million INR | -31.01% |
| 2023 Q1 | 234.91 Million INR | 528.98% |
| 2023 Q2 | 202.98 Million INR | -13.59% |
| 2023 FY | 754.2 Million INR | 108.49% |
| 2022 Q1 | 17.55 Million INR | -57.95% |
| 2022 FY | 361.74 Million INR | 2.6% |
| 2022 Q2 | 201.38 Million INR | 1047.15% |
| 2022 Q4 | 37.34 Million INR | -64.59% |
| 2022 Q3 | 105.46 Million INR | -47.63% |
| 2021 Q2 | 126.72 Million INR | 21.32% |
| 2021 Q4 | 41.74 Million INR | -47.59% |
| 2021 FY | 352.58 Million INR | 59.23% |
| 2021 Q1 | 104.45 Million INR | 43.24% |
| 2021 Q3 | 79.65 Million INR | -37.14% |
| 2020 Q3 | 61.19 Million INR | -37.51% |
| 2020 Q2 | 97.93 Million INR | 1022.48% |
| 2020 Q1 | -10.61 Million INR | 67.81% |
| 2020 FY | 221.43 Million INR | 15.52% |
| 2020 Q4 | 72.92 Million INR | 19.17% |
| 2019 Q4 | -32.97 Million INR | -162.78% |
| 2019 FY | 191.68 Million INR | -28.05% |
| 2019 Q1 | 92.91 Million INR | 25.3% |
| 2019 Q2 | 79.22 Million INR | -14.73% |
| 2019 Q3 | 52.52 Million INR | -33.7% |
| 2018 Q2 | 4.12 Million INR | -94.74% |
| 2018 Q4 | 74.15 Million INR | -32.47% |
| 2018 FY | 266.39 Million INR | 170.71% |
| 2018 Q1 | 78.4 Million INR | 35.69% |
| 2018 Q3 | 109.8 Million INR | 2564.62% |
| 2017 Q2 | 83.44 Million INR | 200.44% |
| 2017 FY | 98.4 Million INR | -18.23% |
| 2017 Q4 | 57.78 Million INR | 43.53% |
| 2017 Q3 | 40.25 Million INR | -51.75% |
| 2017 Q1 | -83.07 Million INR | -270.32% |
| 2016 Q3 | -16.42 Million INR | -126.64% |
| 2016 FY | 120.35 Million INR | -74.92% |
| 2016 Q1 | 26.36 Million INR | -94.0% |
| 2016 Q2 | 61.63 Million INR | 133.82% |
| 2016 Q4 | 48.77 Million INR | 397.05% |
| 2015 Q3 | -51.54 Million INR | -180.61% |
| 2015 FY | 479.95 Million INR | 250.33% |
| 2015 Q1 | 27.92 Million INR | -31.17% |
| 2015 Q2 | 63.94 Million INR | 129.01% |
| 2015 Q4 | 439.63 Million INR | 952.93% |
| 2014 Q3 | 6.65 Million INR | -90.58% |
| 2014 Q4 | 40.56 Million INR | 509.85% |
| 2014 Q2 | 70.59 Million INR | 267.84% |
| 2014 Q1 | 19.19 Million INR | -67.95% |
| 2014 FY | 137 Million INR | 8.96% |
| 2013 Q3 | -13.95 Million INR | -123.48% |
| 2013 Q4 | 59.86 Million INR | 528.92% |
| 2013 Q1 | 20.36 Million INR | -52.91% |
| 2013 FY | 125.73 Million INR | 46.91% |
| 2013 Q2 | 59.45 Million INR | 191.87% |
| 2012 Q1 | 14.69 Million INR | -67.1% |
| 2012 FY | 85.58 Million INR | 12.2% |
| 2012 Q4 | 43.25 Million INR | 239.77% |
| 2012 Q3 | -30.94 Million INR | -152.83% |
| 2012 Q2 | 58.58 Million INR | 298.61% |
| 2011 Q4 | 44.67 Million INR | 295.33% |
| 2011 FY | 76.28 Million INR | -29.66% |
| 2011 Q2 | 44.55 Million INR | 0.0% |
| 2011 Q3 | -22.87 Million INR | -151.33% |
| 2010 FY | 108.45 Million INR | 5.57% |
| 2009 FY | 102.74 Million INR | 36.51% |
| 2008 FY | 75.26 Million INR | 2.54% |
| 2007 FY | 73.39 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 87.753% |
| Hester Biosciences Limited | 188.89 Million INR | -299.281% |
| Aarti Drugs Limited | 1.71 Billion INR | 56.002% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 65.228% |
| Alembic Limited | 2.68 Billion INR | 71.923% |
| Alkem Laboratories Limited | 17.95 Billion INR | 95.8% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -926.417% |
| Bajaj HealthCare Limited | -837.93 Million INR | 190.008% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -10534.532% |
| Brooks Laboratories Limited | -195.91 Million INR | 484.956% |
| Eris Lifesciences Limited | 3.91 Billion INR | 80.759% |
| FDC Limited | 3.05 Billion INR | 75.29% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 83.983% |
| Gufic Biosciences Limited | 861.35 Million INR | 12.44% |
| Hikal Limited | 696 Million INR | -8.362% |
| Ind-Swift Limited | 142.31 Million INR | -429.959% |
| Innova Captab Limited | 943.45 Million INR | 20.059% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 43.896% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -235.753% |
| Jubilant Pharmova Limited | 771 Million INR | 2.179% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 19.168% |
| Lupin Limited | 19.14 Billion INR | 96.061% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 931.378% |
| Medico Remedies Limited | 82.9 Million INR | -809.673% |
| Morepen Laboratories Limited | 961.59 Million INR | 21.568% |
| Nectar Lifesciences Limited | 49.95 Million INR | -1409.912% |
| Orchid Pharma Limited | 921.66 Million INR | 18.17% |
| Procter & Gamble Health Limited | 2 Billion INR | 62.474% |
| RPG Life Sciences Limited | 876.6 Million INR | 13.963% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -416.526% |
| Sigachi Industries Limited | 571.8 Million INR | -31.899% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 113.292% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 74.883% |
| Themis Medicare Limited | 435.23 Million INR | -73.285% |
| Unichem Laboratories Limited | -704.74 Million INR | 207.018% |
| Vaishali Pharma Limited | 7.18 Million INR | -10391.042% |
| Wanbury Limited | 559.56 Million INR | -34.784% |
| Windlas Biotech Limited | 581.87 Million INR | -29.617% |
| ZIM Laboratories Limited | 172.46 Million INR | -337.309% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 82.084% |
| Ipca Laboratories Limited | 5.47 Billion INR | 86.221% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.212% |
| Venus Remedies Limited | 284.9 Million INR | -164.717% |
| Sakar Healthcare Limited | 116.7 Million INR | -546.224% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 97.623% |
| Divi's Laboratories Limited | 16 Billion INR | 95.286% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 53.303% |
| Mankind Pharma Limited | 19.12 Billion INR | 96.057% |
| Sequent Scientific Limited | -358.69 Million INR | 310.265% |
| Laurus Labs Limited | 1.6 Billion INR | 53.024% |
| Neuland Laboratories Limited | 3 Billion INR | 74.867% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 86.352% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 105.022% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 98.046% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -67.702% |
| Wockhardt Limited | -4.63 Billion INR | 116.289% |
| Bal Pharma Limited | 73.92 Million INR | -920.266% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 98.646% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 0.045% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -420.103% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 83.5% |
| Shilpa Medicare Limited | 318.74 Million INR | -136.618% |
| Valiant Laboratories Limited | 3.19 Million INR | -23498.279% |
| Ajanta Pharma Limited | 8.16 Billion INR | 90.759% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -1510.279% |
| Granules India Limited | 4.05 Billion INR | 81.392% |
| Medicamen Biotech Limited | 109.31 Million INR | -589.965% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -197.936% |
| Piramal Enterprises Limited | -16.83 Billion INR | 104.48% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 95.447% |
| NATCO Pharma Limited | 13.88 Billion INR | 94.567% |
| Suven Life Sciences Limited | -1.05 Billion INR | 171.777% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 482.292% |
| Strides Pharma Science Limited | -706.14 Million INR | 206.806% |
| Indoco Remedies Limited | 984.6 Million INR | 23.4% |
| Alpa Laboratories Limited | 167.76 Million INR | -349.558% |
| Lasa Supergenerics Limited | -217.3 Million INR | 447.069% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 119.478% |